Literature DB >> 30914411

The Pseudogene Olfr29-ps1 Promotes the Suppressive Function and Differentiation of Monocytic MDSCs.

Wencong Shang1,2,3, Yunhuan Gao1,2,3, Zhenzhen Tang1,2,3, Yuan Zhang1,2,3, Rongcun Yang4,2,3.   

Abstract

Long noncoding RNA (lncRNA) plays a critical role in many biological processes, such as cell differentiation and development. However, few studies about lncRNAs regulating the differentiation and development of myeloid-derived suppressor cells (MDSCs) exist. In this study, we identified a lncRNA pseudogene, Olfr29-ps1, which was expressed in MDSCs and upregulated by the proinflammatory cytokine IL6. The Olfr29-ps1 in vertebrates is conserved, and the similarity between the Olfr29-ps1 and human OR1F2P sequence is 43%. This lncRNA promoted the immunosuppressive function and differentiation of monocytic (Mo-)MDSCs in vitro and in vivo It directly sponged miR-214-3p to downregulate miR-214-3p, which may target MyD88 to modulate the differentiation and development of MDSCs. The functions of Olfr29-ps1 were dependent on IL6-mediated N 6-methyladenosine (m6A) modification, which not only enhanced Olfr29-ps1, but also promoted the interaction of Olfr29-ps1 with miR-214-3p Thus, our results demonstrated that the pseudogene Olfr29-ps1 may regulate the differentiation and function of MDSCs through a m6A-modified Olfr29-ps1/miR-214-3p/MyD88 regulatory network, revealing a mechanism for the regulation of myeloid cells and also providing potential targets for antitumor immunotherapy. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 30914411     DOI: 10.1158/2326-6066.CIR-18-0443

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  33 in total

Review 1.  Long noncoding RNA loss in immune suppression in cancer.

Authors:  Qingsong Hu; Sergey D Egranov; Chunru Lin; Liuqing Yang
Journal:  Pharmacol Ther       Date:  2020-05-29       Impact factor: 12.310

Review 2.  Tumor immune microenvironment lncRNAs.

Authors:  Eun-Gyeong Park; Sung-Jin Pyo; Youxi Cui; Sang-Ho Yoon; Jin-Wu Nam
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

3.  The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells.

Authors:  Dina Mofed; Jihad I Omran; Salwa Sabet; Ahmed A Baiomy; Marwan Emara; Tamer Z Salem
Journal:  Mol Biol Rep       Date:  2022-10-07       Impact factor: 2.742

Review 4.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

5.  Transcriptional regulatory networks of circulating immune cells in type 1 diabetes: A community knowledgebase.

Authors:  Scott A Ochsner; Rudolf T Pillich; Deepali Rawool; Jeffrey S Grethe; Neil J McKenna
Journal:  iScience       Date:  2022-06-11

6.  Strategies to Study the Functions of Pseudogenes in Mouse Models of Cancer.

Authors:  Ilah Bok; Florian A Karreth
Journal:  Methods Mol Biol       Date:  2021

Review 7.  Myeloid-derived suppressor cells (MDSC): When good intentions go awry.

Authors:  Maria Dulfary Sanchez-Pino; Matthew J Dean; Augusto C Ochoa
Journal:  Cell Immunol       Date:  2021-02-04       Impact factor: 4.868

Review 8.  Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers.

Authors:  Hui Xuan Lim; Tae Sung Kim; Chit Laa Poh
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 9.  Elucidating the Functions of Non-Coding RNAs from the Perspective of RNA Modifications.

Authors:  Venkata Naga Srikanth Garikipati; Shizuka Uchida
Journal:  Noncoding RNA       Date:  2021-05-11

Review 10.  Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Authors:  Ya-Nan Pi; Wen-Cai Qi; Bai-Rong Xia; Ge Lou; Wei-Lin Jin
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.